Heart Failure Research

Heart failure, also known as congestive heart failure or CHF, is an inability of the heart to pump sufficient blood around the body.Heart failure typically occurs secondary to an existing pathology that alters cardiac function. Examples of syndromes that can precede heart failure include myocardial infarction, arrhythmia or infection. These can also cause dilated cardiomyopathy, a condition which accounts for approximately one third of all cases of heart failure. The pathogenesis of heart failure is cyclical and progressive; endogenous mechanisms, which are activated during heart failure in an attempt to counteract the symptoms, actually worsen cardiac function. Cardiac dysfunction, either systolic or diastolic, triggers a decrease in stroke volume and a resultant increase in cardiac output. In healthy individuals the body responds to decreases in cardiac output by initiating the renin-angiotensin-aldosterone system (RAAS) to promote fluid retention, and also by activating the sympathetic nervous system to cause peripheral vasoconstriction. Under normal circumstances this counteracts the imbalance in stroke volume, restoring cardiac output to normal levels. In patients with heart failure the increase in blood volume, together with the heightened peripheral resistance and elevated levels of circulating catecholamines, causes an increased load on the already weakened ventricles with each contraction, and the stroke volume does not return to normal levels. Repeated cycles of this process further weaken the ventricle walls, prompting ventricular hypertrophy and a decreased force of contraction.

Heart Failure Research Products Targets

Products for Heart Failure Research - Page 13

  1. Cat.No. Product Name Information/Activity
  2. BCC6092 AR-C 102222 253771-21-0 AR-C 102222 chemical structure
  3. BCC7506 BYK 191023 dihydrochloride Potent and selective inhibitor of iNOS BYK 191023 dihydrochloride chemical structure
  4. BCC6824 EIT hydrobromide 1071-37-0 EIT hydrobromide chemical structure
  5. BCC6862 2-Iminopiperidine hydrochloride 16011-96-4 2-Iminopiperidine hydrochloride chemical structure
  6. BCC6837 S-Isopropylisothiourea hydrobromide 4269-97-0 S-Isopropylisothiourea hydrobromide chemical structure
  7. BCC6791 (S)-Methylisothiourea sulfate 867-44-7 (S)-Methylisothiourea sulfate chemical structure
  8. BCC5706 L-NIL hydrochloride 150403-89-7 L-NIL hydrochloride chemical structure
  9. BCC7057 1400W dihydrochloride 1400W dihydrochloride is a potent and selective inhibitor of human inducible NO synthase with Ki values of 7 nM. 1400W dihydrochloride chemical structure
  10. BCC7647 ARL 17477 dihydrochloride 866914-87-6 ARL 17477 dihydrochloride chemical structure
  11. BCC6770 3-Bromo-7-nitroindazole 3-Bromo-7-nitroindazole is a more potent and selective inhibitor of neuronal nitric oxide synthase (nNOS) than eNOS or inducible nitric oxide synthase (iNOS). 3-Bromo-7-nitroindazole affects the intercellular messenger nitric oxide (NO) synthesis throughout the body and brain. 3-Bromo-7-nitroindazole chemical structure

Items 121 to 130 of 148 total